查看文章

Programed ventricular stimulation (PVS) is a risk stratification tool in patients at risk for adverse arrhythmia outcomes. Patients with negative PVS may yet be at risk for adverse arrhythmia‐related events, particularly in the presence of symptomatic ventricular arrhythmias (VA).

To investigate the long‐term outcomes of real‐world patients with symptomatic VA without indication for device therapy and negative PVS, and to examine the role of cardiac scaring on arrhythmia recurrence.

Patients with symptomatic VA, and late gadolinium enhancement cardiac magnetic resonance imaging (LGE‐CMR), and negative PVS testing were included. All patients underwent placement of implantable cardiac monitors (ICM). Survival analysis was performed to investigate the impact of LGE‐CMR findings on survival free from adverse arrhythmic events.

Seventy‐eight patients were …